SCHEMBL5867599

SCHEMBL5867599

O=C(Nc1cc(C2CC2)n[nH]1)c1cccs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.52
RAB9A P51151 8/20 0.52
NPC1 O15118 7/20 0.52
SMN1; SMN2 Q16637 5/20 0.47
MAPT P10636 4/20 0.47
PKM P14618 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
TDP1 Q9NUW8 1/20 0.47
HDAC1 Q13547 1/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 2/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
MAPK1 P28482 1/20 0.45
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5867509 0.88 RAB9A (0.43) HSD17B10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5867840 0.79 TYK2 (0.46) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL5867670 0.79 CCNA2 (0.59) RAB9ANPC1MAPT
SCHEMBL5867908 0.79 CASP3 (0.44) RAB9ANPC1MAPTPKMKMT2A
SCHEMBL5867981 0.78 TMIGD3 (0.64) RAB9AHDAC1CASP3SENP8SENP7
SCHEMBL5867725 0.77 CDK2 (0.64) RAB9ANPC1SMN1; SMN2MAPTPKM
SCHEMBL5867747 0.76 RAB9A (0.51) RAB9ANPC1SMN1; SMN2MAPTPKM
SCHEMBL5867721 0.75 KCNMA1 (0.44) RAB9ANPC1KMT2AMEN1
SCHEMBL5867482 0.75 CCNA2 (0.64) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL5867600 0.75 CCNA2 (0.60) RAB9ANPC1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034049-B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents PHARMACIA ITALIA S.P.A. (IT) 2006-04-25 US disclosed
EP-1202733-B1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-10-05 EP disclosed
EP-1202733-A4 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2003-05-14 EP disclosed
CN-1373662-A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents PHARMACIA & UP JOHN S P A (IT) 2002-10-09 CN disclosed
EP-1202733-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP disclosed
US-6218418-B1 THERAPY OF CELL PROLIFERATIVE DISORDERS ASSOCIATED WITH AN ALTERED CELL DEPENDENT KINASE ACTIVITY BY ADMINISTERING AMINO PYRAZOLE DERIVATIVE TO MAMMAL PHARMACIA & UPJOHN S.P.A (IT) 2001-04-17 US disclosed
WO-2001012189-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-02-22 WO disclosed